Collectively, these observations imply that TREM2 variants may modulate microglial function through tau-specific mechanisms in atypical AD, thereby indirectly influencing disease progression rather than directly affecting Aβ pathology. This evidence concerns the gene TREM2 and Alzheimer disease.